RNA干扰在口腔癌基因治疗上的研究进展(4)
[17] Zhang Q，Zhang ZF，Rao JY，et a1.Treatment with siRNA and antisense oligonucleotides targeted to HIF-lalpha induced apoptosis in human tongue squamous cell carcinomas，Int J Cancer，2004.1l1(6)：849
[18] Edelstein ML，Abedi MR，Wixon J.Gene therapy clinical trials worldwide to 2007 - an update.J Gene Med，2007，9(10)：833-842.
[19] Doody JF，Wang Y，Patel SN，et a1.Inhibitory activity of cetuximab on epidermal gmwth factor receptor mutations in non small cell lung cancer.Mol Cancer Ther，2007，6(10)：264212651.
[20] Pfister DG，Su YB，Kraus DH，et a1.Concurrent cetuximab，cisplatin，and concomitant boost radiotherapy for locoregionally advanced，squamous cell head and neck cancer：a pilot phaseⅡ study of a new combined-modality paradigm.J Clin 0nc01.2006，24(7)：1072-1078.
[21] Bonner JA，Harari PM，Giralt J，et aL Radiotheralpy plus cenlximab for squamous-cell carcinoma of the head and neck.N Engl J Med，2006，354(6)：567.578.
[22] Burtness B，Goldwasser MA，Flood W，et a1.PhaseⅢ randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recunrrent head and neck cancer：an eastern cooperative oncology group study.J Clin Oncol，2005，23(34)：8646-8654, http://www.100md.com(于婷婷等)
[18] Edelstein ML，Abedi MR，Wixon J.Gene therapy clinical trials worldwide to 2007 - an update.J Gene Med，2007，9(10)：833-842.
[19] Doody JF，Wang Y，Patel SN，et a1.Inhibitory activity of cetuximab on epidermal gmwth factor receptor mutations in non small cell lung cancer.Mol Cancer Ther，2007，6(10)：264212651.
[20] Pfister DG，Su YB，Kraus DH，et a1.Concurrent cetuximab，cisplatin，and concomitant boost radiotherapy for locoregionally advanced，squamous cell head and neck cancer：a pilot phaseⅡ study of a new combined-modality paradigm.J Clin 0nc01.2006，24(7)：1072-1078.
[21] Bonner JA，Harari PM，Giralt J，et aL Radiotheralpy plus cenlximab for squamous-cell carcinoma of the head and neck.N Engl J Med，2006，354(6)：567.578.
[22] Burtness B，Goldwasser MA，Flood W，et a1.PhaseⅢ randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recunrrent head and neck cancer：an eastern cooperative oncology group study.J Clin Oncol，2005，23(34)：8646-8654, http://www.100md.com(于婷婷等)